Sexually Transmitted Infections in Migrant Women
August 11, 2026 updated by: Emine Aksut Akcay, Kahramanmaras Sutcu Imam University
The Effect of Sexual Health Self-Efficacy and Reproductive Autonomy in Migrant Women Through Sexual Transmission Infections A Randomized Controlled Study
The main objective of this study is to evaluate the effect of structured sexual health education for immigrant women on their levels of sexual health self-efficacy and reproductive autonomy using a randomized controlled design.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sexuality is a fundamental aspect of human life that encompasses biological, psychological, and social dimensions and is shaped by individuals' personality traits, life experiences, and social conditions.
Sexual satisfaction and adjustment are related not only to physical processes but also to psychological well-being and interpersonal relationships.
In this context, sexual self-efficacy-defined as an individual's belief in their ability to manage emotions and behaviors in sexual situations-plays an important role, while reproductive autonomy refers to the ability to freely decide whether and when to have children.
Migrant women may be more vulnerable in these areas due to various social and structural barriers; therefore, efforts aimed at strengthening sexual health self-efficacy and reproductive autonomy are considered important.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kahramanmaraş, Turkey (Türkiye)
- Kahramanmaras Sutcu Imam University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- To be eligible, applicants must:
- Be 18 years of age or older,
- Have immigrant status and reside in Turkey,
- Be one of the women who applied to or benefited from the services of the
Exclusion Criteria:
- Being under 18 years of age,
- Refusal to give informed consent for participation in the study,
- Having a serious cognitive impairment or psychiatric condition that may prevent regular participation in the training and data collection process,
- Having a severe language barrier that prevents communication during the study process and that cannot be overcome with translation or written materials,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: experimental group
Application Description: The experimental group will receive education on sexually transmitted diseases and will be administered reproductive autonomy and sexual self-efficacy scales.
|
Training Sessions and Topics Session 1: Sexually Transmitted Infections and Women's Health Definition and types of STIs Symptoms and asymptomatic courses in women Relationship of STIs with reproductive health and HIV risk Transmission routes and the importance of testing Session 2: Sexual Health Self-Efficacy and Protective Behaviors The concept of sexual health self-efficacy Protection methods and correct condom use Seeking healthcare and requesting testing Communication with healthcare professionals Session 3: Reproductive Autonomy, Communication, and Rights Reproductive autonomy and decision-making Communication with partners and setting boundaries Confidentiality and consent in healthcare Coping with stigma
|
|
No Intervention: No Intervention: Control Group
No intervention will be made in the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary endpoint will be the difference in mean knowledge scores between baseline (pre-intervention) and post-intervention assessments.
Time Frame: Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.
|
|
Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary endpoint will be the change in the mean RAS score between baseline (pre-intervention) and post-intervention assessments.
Time Frame: Immediately after the intervention is completed.
|
1. Level of Reproductive Autonomy: Participants' level of reproductive autonomy will be assessed using the scale developed by Upadhyay et al.
The Reproductive Autonomy Scale (RAS), developed by (2014) and validated and proven reliable in Turkish by Dursun and Gözüyeşil (2023), will be used for evaluation.
The scale consists of 14 items and three sub-dimensions (Decision Making, Coercion Avoidance, Communication).
The unit of measurement is the scale score, which is calculated as the average score obtained by dividing the total score by the number of items.
Higher scores indicate higher reproductive autonomy.
|
Immediately after the intervention is completed.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sadock, V. A. (1989). Psychosexual dysfunctions and treatment. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (5th ed.). Baltimore, MD: Williams & Wilkins.
- Reissing, E. D., Laliberté, G. M., & Davis, H. J. (2005). Young women's sexual adjustment: The role of sexual self-schema, sexual self-efficacy, sexual aversion and body attitudes. The Canadian Journal of Human Sexuality, 14(3-4).
- Eysenck, H. J. (1971). Hysterical personality and sexual adjustment, attitudes and behavior. Journal of Sex Research, 7, 274-281.
- Bailes, S., Creti, L., Fichten, C. S., Libman, E., Brender, W., & Amsel, R. (1998). Sexual self-efficacy scale for female functioning. In C. M. Davis, W. L. Yarber, R. Bauserman, G. Schreer, & S. L. Davis (Eds.), Handbook of sexuality-related measures (pp. 531-534). London, England: Sage.
- Grace KT, Anderson JC. Reproductive Coercion: A Systematic Review. Trauma Violence Abuse. 2018 Oct;19(4):371-390. doi: 10.1177/1524838016663935. Epub 2016 Aug 16.
- Creti L, Libman E. Cognitions and sexual expression in the aging. J Sex Marital Ther. 1989 Summer;15(2):83-101. doi: 10.1080/00926238908403814.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2026
Primary Completion (Actual)
March 1, 2026
Study Completion (Actual)
August 1, 2026
Study Registration Dates
First Submitted
March 9, 2026
First Submitted That Met QC Criteria
March 12, 2026
First Posted (Actual)
March 13, 2026
Study Record Updates
Last Update Posted (Actual)
August 13, 2026
Last Update Submitted That Met QC Criteria
August 11, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KahramanmarasSIUniversity (Registry Identifier: KahramanmarasSIUniversity)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
I do not approve of sharing ipd
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.